PwC's Next in Health · 2026-05-04 · 18 min
As the 2026 midterm elections approach, healthcare leaders are asking whether this is just another policy cycle or a more pivotal moment in an increasingly complex and fragmented landscape. In this episode of PwC’s Next in Health, Glenn Hunzinger speaks with Kelly Griffin and Philip Sclafani about how shifting policy dynamics, persistent cost pressures, and rapid industry transformation are reshaping strategy across the healthcare ecosystem.
US Medtech Deals Midyear Outlook 2026: Why companies are investing through uncertainty48 / 100US Health Services Deals Midyear Outlook 2026: Why investors are focusing on resilience and value creation72 / 100US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into Growth76 / 100Strategies for accessing funding and managing risk in rural health transformation2026 Healthcare Investment Trends